Fatima Cody Stanford

Dr. Fatima Cody Stanford, an expert in obesity medicine, reframes our approach to obesity and discusses effective medications for treatment. They explore patient goals, treatment options, including surgery and behavioral support, and the underutilization of evidence-based treatments. The episode also includes an ad for Babble language learning app.

Harvard professor Dr. Fatima Cody Stanford discusses GLP-1 agonist drugs like Ozempic, their impact on weight management, personalized healthcare approaches, challenges with access to medication, and the importance of seeking proper medical treatment for obesity.

Dr. Fatima Cody Stanford and Jonathan Gruber discuss the potential of GLP-1 drugs for obesity treatment, addressing their efficacy, insurance coverage issues, and implications for the US fiscal health. They explore the disparities in Medicare coverage, complexities of drug pricing, and market competition in the healthcare industry. The episode delves into setting reasonable drug prices, innovative mechanisms for negotiation, and economic impacts of expanding coverage for GLP-1 drugs.